Point72 Asset Management
KYTH

Point72 Asset Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Point72 Asset Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15,200
Closed -$583K – 860
2014
Q2 		$583K Buy
+15,200
New +$531K ﹤0.01% 635

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Point72 Asset Management's KYTH Position: Q3 2014 in Review

Point72 Asset Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2014, closing a stake of 15,200 shares — an estimated $583K sold.

Point72 Asset Management first reported a position in KYTH in Q2 2014 and held it in 1 quarter. The position peaked at $583K in Q2 2014. 110 funds tracked by Wall St. Rank hold KYTH as of Q3 2014.

  • Point72 Asset Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2014 after selling out during the quarter.
  • Point72 Asset Management sold 15,200 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2014, an estimated $583K.
  • Point72 Asset Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2014 and held it in 1 quarter.
  • Point72 Asset Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $583K in Q2 2014.
  • 110 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2014.

Based on Point72 Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.